TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24644249

Group type: EXPERIMENTAL
Intervention: Posaconazole
Number of subjects: 130

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 130
Study: 22576327

Group type: EXPERIMENTAL
Intervention: Intravesical 40 mg HA, 10 ml of 2 % lidocaine and 5 ml of 8.4 % sodium bicarbonate
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intravesical 40 mg HA
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intravesical 10 ml of 2 % lidocaine and 5 ml of 8.4 % sodium bicarbonate
Number of subjects: 48
Study: 20067331

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 17506903

Group type: EXPERIMENTAL
Intervention: Supervised, weekly, hospital-based exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsupervised home exercise
Number of subjects: 0
Study: 15951939

Group type: EXPERIMENTAL
Intervention: Biliary stent
Number of subjects: 81

Group type: COMPARATOR
Intervention: T-tube
Number of subjects: 81
Study: 12950540

Group type: EXPERIMENTAL
Intervention: Post Mode Switching Overdrive Pacing (PMOP) active (120 beats/min for 2 min)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Post Mode Switching Overdrive Pacing (PMOP) inactive
Number of subjects: 37
Study: 11187670

Group type: EXPERIMENTAL
Intervention: Gibbs sampling technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Techniques based on one long single chain and on multiple chains
Number of subjects: 0
Study: 8876938

Group type: EXPERIMENTAL
Intervention: Dimethindene maleate (Fenistil OAD)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Loratadine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Dimethindene maleate (Fenistil retard)
Number of subjects: 18
Study: 1716558

Group type: EXPERIMENTAL
Intervention: Scopolamine (3 doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral anticholinergic agent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healthy elderly)
Number of subjects: 0
Study: 6296673

Group type: EXPERIMENTAL
Intervention: Herpesvirus infections (primary or reactivated) in the first three months after transplantation
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cytomegalovirus infections in less heavily immunosuppressed recipients of organs from living related donors
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low OKT4/OKT8 ratios (< 1.0)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Renal dysfunction with low OKT4/OKT8 ratio
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Monitoring of T-lymphocyte subsets
Number of subjects: 28
Study: 31913424

Group type: EXPERIMENTAL
Intervention: Lumateperone 42 mg
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Lumateperone 28 mg
Number of subjects: 450

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study: 30799959

Group type: EXPERIMENTAL
Intervention: Monthly dual injections
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Daily oral tablets
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Monthly vaginal rings
Number of subjects: 88
Study: 28647746

Group type: EXPERIMENTAL
Intervention: Guided IRT
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Unguided IRT
Number of subjects: 127

Group type: COMPARATOR
Intervention: Nightmare frequency control group
Number of subjects: 127

Group type: COMPARATOR
Intervention: Narrative control group
Number of subjects: 127
Study: 27048954

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 24876619

Group type: EXPERIMENTAL
Intervention: Oral hepatic-directed vesicle-insulin (HDV-I) 0.05 U/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral hepatic-directed vesicle-insulin (HDV-I) 0.1 U/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral hepatic-directed vesicle-insulin (HDV-I) 0.2 U/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral hepatic-directed vesicle-insulin (HDV-I) 0.4 U/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 22178160

Group type: EXPERIMENTAL
Intervention: microbubbles with three‐dimensional (3‐D) guided high mechanical index impulses (1.18) for 15 min
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo without ultrasound
Number of subjects: 10
Study: 19675330

Group type: EXPERIMENTAL
Intervention: Weight lifting
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study: 17451119

Group type: EXPERIMENTAL
Intervention: Microdebrider
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard instruments
Number of subjects: 50
Study: 15111663

Group type: EXPERIMENTAL
Intervention: CEMRA
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Combination of DUS and CEMRA
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Selective DUS review
Number of subjects: 167
Study: 12183696

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude thrust manipulation to the talocrural joint
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (no manipulation)
Number of subjects: 41
Study: 10547079

Group type: EXPERIMENTAL
Intervention: Losartan, 75 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Continuous transdermal GTN, 0.6 mg/h
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8904738

Group type: EXPERIMENTAL
Intervention: Zolpidem
Number of subjects: 304

Group type: COMPARATOR
Intervention: Phenobarbital combined with promethazine
Number of subjects: 304
Study: 1855357

Group type: EXPERIMENTAL
Intervention: 10 mg/day enalapril
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 20 mg/day enalapril
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 6185553

Group type: EXPERIMENTAL
Intervention: Cromolyn 2% (nonirritant dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no cromolyn)
Number of subjects: 10
Study: 31602822

Group type: EXPERIMENTAL
Intervention: Sodium citrate in capsules (500 mg·kg‐1 body mass)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sodium citrate in solution (500 mg·kg‐1 body mass)
Number of subjects: 24
Study: 29301919

Group type: EXPERIMENTAL
Intervention: (bio)feedback-guided training
Number of subjects: 218

Group type: COMPARATOR
Intervention: Enhanced education group
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 218
Study: 26748056

Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide implant
Number of subjects: 146

Group type: COMPARATOR
Intervention: Implant removal surgeries
Number of subjects: 146
Study: 24281290

Group type: EXPERIMENTAL
Intervention: IV racemic ketamine 0.5 mg/kg preincisional +0.25 mg/kg/h for 48 h
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Epidural racemic ketamine 0.5 mg/kg preincisional +0.25 mg/kg/h for 48 h
Number of subjects: 104

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: All groups (Kiv, Kep, S)
Number of subjects: 104
Study: 24160246

Group type: EXPERIMENTAL
Intervention: Personalised Oral Hygiene Advice (OHA)
Number of subjects: 1860

Group type: COMPARATOR
Intervention: Routine Oral Hygiene Advice (OHA)
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: No Periodontal Instrumentation (PI)
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: 6 monthly Periodontal Instrumentation (PI)
Number of subjects: 1860

Group type: EXPERIMENTAL
Intervention: 12 monthly Periodontal Instrumentation (PI)
Number of subjects: 1860
Study: 20648579

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node dissection (SLND)
Number of subjects: 3983

Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 3983
Study: 18468012

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (Group S)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (Group C)
Number of subjects: 16
Study: 16352880

Group type: EXPERIMENTAL
Intervention: Chewing gum containing xylitol + calcium lactate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Chewing gum containing only xylitol
Number of subjects: 10

Group type: COMPARATOR
Intervention: No gum chewing (control)
Number of subjects: 10
Study: 12496308

Group type: EXPERIMENTAL
Intervention: Emotion-oriented care training program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 10823260

Group type: EXPERIMENTAL
Intervention: Defibrotide 800 mg/day
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Defibrotide 1200 mg/day
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 8938895

Group type: EXPERIMENTAL
Intervention: Very Low-Caloric Diet (VLCD)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Very Low-Caloric Diet (VLCD) after initial control period
Number of subjects: 20
Study: 1389945

Group type: EXPERIMENTAL
Intervention: Flosequinan (100 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 3996172

Group type: EXPERIMENTAL
Intervention: Social skills intervention group (daily social-learning exercises)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (learning medical facts about diabetes care)
Number of subjects: 21
Study: 30421178

Group type: EXPERIMENTAL
Intervention: 20 mg melatonin a day, administered 5 days a week for 28 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20 mg melatonin a day
Number of subjects: 60
Study: 29876978

Group type: EXPERIMENTAL
Intervention: Online self-report survey
Number of subjects: 58

Group type: COMPARATOR
Intervention: Observational audit
Number of subjects: 58
Study: 26546845

Group type: EXPERIMENTAL
Intervention: Moderate sedation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deep sedation/general anesthesia
Number of subjects: 0
Study: 24169821

Group type: EXPERIMENTAL
Intervention: 5% human albumin (HA)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (HES)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Ringer's lactate (RL)
Number of subjects: 240
Study: 22290132

Group type: EXPERIMENTAL
Intervention: Training group (34 observers)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nontraining group (30 observers)
Number of subjects: 64
Study: 20557390

Group type: EXPERIMENTAL
Intervention: Information audiotape given the day prior to hospital discharge, encouraged to listen multiple times.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no audiotape intervention).
Number of subjects: 120
Study: 18958169

Group type: EXPERIMENTAL
Intervention: Viewing a hated face
Number of subjects: 17
Study: 15825529

Group type: EXPERIMENTAL
Intervention: 0.9% sodium chloride ophthalmic solution, one instillation four times daily for 21 days
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no drops)
Number of subjects: 49
Study: 12586622

Group type: EXPERIMENTAL
Intervention: IEmRNA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Antigenemia
Number of subjects: 80
Study: 10506606

Group type: EXPERIMENTAL
Intervention: DepoCyt 50 mg once every 2 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Free ara-C 50 mg twice a week for 1 month
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: DepoCyt
Number of subjects: 28

Group type: COMPARATOR
Intervention: Free ara-C
Number of subjects: 28
Study: 8894655

Group type: EXPERIMENTAL
Intervention: Dalteparin 50 IU/kg b.w. s.c. b.i.d.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dalteparin 75 IU/kg b.w. s.c. b.i.d.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dalteparin 100 IU/kg b.w. s.c. b.i.d.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (Heparin)
Number of subjects: 20
Study: 7963170

Group type: EXPERIMENTAL
Intervention: Integrated interview style
Number of subjects: 82

Group type: COMPARATOR
Intervention: Nonintegrated interview style
Number of subjects: 82
Study: 2821643

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2 mg and 4 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31833020

Group type: EXPERIMENTAL
Intervention: Dating Matters intervention
Number of subjects: 3301

Group type: COMPARATOR
Intervention: Standard-of-care TDV prevention program
Number of subjects: 3301
Study: 30070742

Group type: EXPERIMENTAL
Intervention: Gastric stretch with cooling (6°C)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Gastric stretch (37°C)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Peppermint oil capsules (menthol)
Number of subjects: 9
Study: 26806710

Group type: EXPERIMENTAL
Intervention: Traditional paper letters (TPL)
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Short text messages (STM)
Number of subjects: 721

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 721
Study: 27196485

Group type: EXPERIMENTAL
Intervention: Nefopam (20 mg administered before surgery)
Number of subjects: 83
Study: 23583433

Group type: EXPERIMENTAL
Intervention: 25 mg eluxadoline
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: 200 mg eluxadoline
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: 100 mg eluxadoline
Number of subjects: 807

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 807
Study: 21916043

Group type: EXPERIMENTAL
Intervention: Ultragrivac vaccine with 10 day interval
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ultragrivac vaccine with 21 day interval
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with 10 day interval
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with 21 day interval
Number of subjects: 100
Study: 19212269

Group type: EXPERIMENTAL
Intervention: Whole-body magnetic resonance imaging (WB-MRI) combined with whole-body magnetic resonance angiography (WB-MRA)
Number of subjects: 65
Study: 16905951

Group type: EXPERIMENTAL
Intervention: Moderate red wine consumption (one glass daily for 3 weeks)
Number of subjects: 0
Study: 14963287

Group type: EXPERIMENTAL
Intervention: Cerebral microdialysis (MD)
Number of subjects: 13
Study: 11298665

Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg on day 7 with propranolol 80 mg twice daily for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Almotriptan 12.5 mg on day 7 without propranolol
Number of subjects: 12
Study: 10674661

Group type: EXPERIMENTAL
Intervention: Whole cell/recombinant B subunit cholera vaccine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 8697924

Group type: EXPERIMENTAL
Intervention: Low dose aspirin (ASA, 50mg/day) for more than two weeks
Number of subjects: 11
Study: 2752277

Group type: EXPERIMENTAL
Intervention: DS (word recognition and decoding skills)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: OWLS (oral and written language)
Number of subjects: 178

Group type: COMPARATOR
Intervention: CSS (classroom survival skills, alternative treatment control)
Number of subjects: 178
Study: 786671

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indoprofen (up to 400 mg)
Number of subjects: 0
Study: 30987867

Group type: EXPERIMENTAL
Intervention: SVM method
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Linear formulation method
Number of subjects: 46
Study: 28445790

Group type: EXPERIMENTAL
Intervention: Nurse-led group treatment for insomnia based on cognitive behavioral therapy techniques; 2 days of training for nurses.
Number of subjects: 165

Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 165
Study: 25677254

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Paroxetine (Ph)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Combination (Comb)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 228
Study: 23720354

Group type: EXPERIMENTAL
Intervention: Multi-agent chemotherapy including high dose methotrexate, Ara-C, and intrathecal treatment
Number of subjects: 463

Group type: COMPARATOR
Intervention: CNS positive group
Number of subjects: 463
Study: 20644123

Group type: EXPERIMENTAL
Intervention: Tumor-negative SLNs
Number of subjects: 240

Group type: COMPARATOR
Intervention: Tumor-positive SLNs
Number of subjects: 240

Group type: COMPARATOR
Intervention: Factors predictive of tumor-positive SLNs
Number of subjects: 240

Group type: COMPARATOR
Intervention: Factors associated with worse overall survival
Number of subjects: 240
Study: 18385263

Group type: EXPERIMENTAL
Intervention: Oxytocin (10 IU i.v.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methylergometrine (0.2 mg i.v.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oxytocin (10 IU i.v.) in normal controls (n=10)
Number of subjects: 40
Study: 16863695

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic (HALS) approach
Number of subjects: 36
Study: 12799128

Group type: EXPERIMENTAL
Intervention: New Moves program (intervention)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study: 11110856

Group type: EXPERIMENTAL
Intervention: Maternal perception of the onset of lactation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Delayed maternal perception
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low milk transfer
Number of subjects: 60
Study: 2407754

Group type: EXPERIMENTAL
Intervention: Alprazolam (N = 25)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (N = 11)
Number of subjects: 36
Study: 38822

Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: oxprenolol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: sotalol
Number of subjects: 33
Study: 31691153

Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate and polyester mesh
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (staples)
Number of subjects: 54
Study: 30982995

Group type: EXPERIMENTAL
Intervention: Group 1 (G1): 18-35 years old
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Group 2 (G2): 40-60 years old
Number of subjects: 44
Study: 29079101

Group type: EXPERIMENTAL
Intervention: HZ/su vaccine Lot A
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: HZ/su vaccine Lot B
Number of subjects: 651

Group type: EXPERIMENTAL
Intervention: HZ/su vaccine Lot C
Number of subjects: 651

Group type: COMPARATOR
Intervention: Solicited symptoms, unsolicited AEs, and SAEs
Number of subjects: 651

Group type: COMPARATOR
Intervention: Serious AEs (SAEs)
Number of subjects: 651

Group type: COMPARATOR
Intervention: Potential immune-mediated diseases (pIMDs)
Number of subjects: 651
Study: 25681466

Group type: EXPERIMENTAL
Intervention: Target temperature management at 33°C
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Target temperature management at 36°C
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Cardiac arrest survivors
Number of subjects: 652

Group type: COMPARATOR
Intervention: Control group of matched patients with ST-segment-elevation myocardial infarction
Number of subjects: 652
Study: 23839254

Group type: EXPERIMENTAL
Intervention: Chorionic membrane (CM) with periodontal pocket therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Periodontal pocket therapy alone (Control)
Number of subjects: 10
Study: 22300693

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 500 mg twice daily for 4 weeks
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 19088307

Group type: COMPARATOR
Intervention: Control formula (n = 25)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Control formula supplemented with PDX and GOS (4 g/liter) (PG4 group; n = 27)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Control formula supplemented with PDX, GOS, and lactulose (4 g/liter) (PGL4 group; n = 27)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Control formula supplemented with PDX, GOS, and lactulose (8 g/liter) (PGL8 group; n = 25)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Breast-fed group (BF group; n = 30)
Number of subjects: 134

Group type: COMPARATOR
Intervention: All formula groups (including control, PG4, PGL4, PGL8)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Bacterial community profiles for BF, PG4, PGL4, and PGL8 groups
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 134
Study: 17169532

Group type: EXPERIMENTAL
Intervention: Cold-response index (CRI) measured as log transformation of the 63% rewarming time upon cold challenge in RP patients (n=50)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Cold-response index (CRI) measured in scleroderma patients (n=46)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Cold-response index (CRI) in controls (n=53)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Single low-level systemic hyperthermia treatment in scleroderma patients (n=46)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Baseline fingertip temperature in primary and scleroderma-associated RP
Number of subjects: 146
Study: 16400513

Group type: EXPERIMENTAL
Intervention: Injection of 20 units of botulinum toxin into the internal anal sphincter
Number of subjects: 30

Group type: COMPARATOR
Intervention: Injection of 0.4 ml of saline into the internal anal sphincter
Number of subjects: 30
Study: 12105311

Group type: EXPERIMENTAL
Intervention: Tiagabine (TGB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9448174

Group type: EXPERIMENTAL
Intervention: Patients without peptic strictures
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Patients with peptic strictures
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (patients without strictures)
Number of subjects: 79
Study: 7639162

Group type: EXPERIMENTAL
Intervention: RV‐>SVC
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: RV‐>patch
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: RV‐>patch + SVC
Number of subjects: 25